Ubiquitin-dependent Proteasomal Degradation of Human Liver Cytochrome P450 2E1

Human liver CYP2E1 is a monotopic, endoplasmic reticulum-anchored cytochrome P450 responsible for the biotransformation of clinically relevant drugs, low molecular weight xenobiotics, carcinogens, and endogenous ketones. CYP2E1 substrate complexation converts it into a stable slow-turnover species degraded largely via autophagic lysosomal degradation. Substrate decomplexation/withdrawal results in a fast turnover CYP2E1 species, putatively generated through its futile oxidative cycling, that incurs endoplasmic reticulum-associated ubiquitin-dependent proteasomal degradation (UPD). CYP2E1 thus exhibits biphasic turnover in the mammalian liver. We now show upon heterologous expression of human CYP2E1 in Saccharomyces cerevisiae that its autophagic lysosomal degradation and UPD pathways are evolutionarily conserved, even though its potential for futile catalytic cycling is low due to its sluggish catalytic activity in yeast. This suggested that other factors (i.e. post-translational modifications or “degrons”) contribute to its UPD. Indeed, in cultured human hepatocytes, CYP2E1 is detectably ubiquitinated, and this is enhanced on its mechanism-based inactivation. Studies in Ubc7p and Ubc5p genetically deficient yeast strains versus corresponding isogenic wild types identified these ubiquitin-conjugating E2 enzymes as relevant to CYP2E1 UPD. Consistent with this, in vitro functional reconstitution analyses revealed that mammalian UBC7/gp78 and UbcH5a/CHIP E2-E3 ubiquitin ligases were capable of ubiquitinating CYP2E1, a process enhanced by protein kinase (PK) A and/or PKC inclusion. Inhibition of PKA or PKC blocked intracellular CYP2E1 ubiquitination and turnover. Here, through mass spectrometric analyses, we identify some CYP2E1 phosphorylation/ubiquitination sites in spatially associated clusters. We propose that these CYP2E1 phosphorylation clusters may serve to engage each E2-E3 ubiquitination complex in vitro and intracellularly.

• Publication year

  2011

• Venue

  Journal of Biological Chemistry

• Publication date

  2011-01-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M110.176685PMID 21209460PMCID PMC3058980
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serine Residues in the Cytosolic Tail of the T-cell Antigen Receptor α-Chain Mediate Ubiquitination and Endoplasmic Reticulum-associated Degradation of the Unassembled Protein*

  2010cited by this paper
• Hepatic Heme-Regulated Inhibitor (HRI) Eukaryotic Initiation Factor 2α Kinase: A Protagonist of Heme-Mediated Translational Control of CYP2B Enzymes and a Modulator of Basal Endoplasmic Reticulum Stress Tone

  2010cited by this paper
• Liver Cytochrome P450 3A Ubiquitination in Vivo by gp78/Autocrine Motility Factor Receptor and C Terminus of Hsp70-interacting Protein (CHIP) E3 Ubiquitin Ligases

  2010cited by this paper
• Liver Cytochrome P450 3A Endoplasmic Reticulum-associated Degradation

  2010cited by this paper
• C Terminus of Hsc70-interacting Protein Promotes Smooth Muscle Cell Proliferation and Survival through Ubiquitin-mediated Degradation of FoxO1*

  2009cited by this paper
• SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.

  2009cited by this paper
• CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases.

  2009cited by this paper
• Hepatic CYP3A Suppression by High Concentrations of Proteasomal Inhibitors: A Consequence of Endoplasmic Reticulum (ER) Stress Induction, Activation of RNA-Dependent Protein Kinase-Like ER-Bound Eukaryotic Initiation Factor 2α (eIF2α)-Kinase (PERK) and General Control Nonderepressible-2 eIF2α Kinase

  2009cited by this paper
• Prediction of Human Drug-Drug Interactions from Time-Dependent Inactivation of CYP3A4 in Primary Hepatocytes Using a Population-Based Simulator

  2009cited by this paper
• A Role for Protein Phosphorylation in Cytochrome P450 3A4 Ubiquitin-dependent Proteasomal Degradation*

  2009cited by this paper
• SCFCdc4 acts antagonistically to the PGC-1alpha transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis.

  2008cited by this paper
• Different phosphorylation states of the anaphase promoting complex in response to antimitotic drugs: A quantitative proteomic analysis

  2008cited by this paper
• Structures of Human Cytochrome P-450 2E1

  2008cited by this paper
• Distinction between human cytochrome P450 (CYP) isoforms and identification of new phosphorylation sites by mass spectrometry.

  2008cited by this paper
• In-depth Analysis of Tandem Mass Spectrometry Data from Disparate Instrument Types*S

  2008cited by this paper
• Ability of CK2β to selectively regulate cellular protein kinases

  2008cited by this paper
• Pathways of Carbamazepine Bioactivation in Vitro. III. The Role of Human Cytochrome P450 Enzymes in the Formation of 2,3-Dihydroxycarbamazepine

  2008cited by this paper
• Cytochrome p450 turnover: regulation of synthesis and degradation, methods for determining rates, and implications for the prediction of drug interactions.

  2008cited by this paper
• FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

  2008cited by this paper
• Characterization of the physiological turnover of native and inactivated cytochromes P450 3A in cultured rat hepatocytes: a role for the cytosolic AAA ATPase p97?

  2007cited by this paper
• Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

  2007cited by this paper
• Cellular proteolytic systems in P450 degradation: evolutionary conservation from Saccharomyces cerevisiae to mammalian liver

  2007cited by this paper
• Kinase-active Interleukin-1 Receptor-associated Kinases Promote Polyubiquitination and Degradation of the Pellino Family

  2007cited by this paper
• Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3

  2007cited by this paper
• Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.

  2007cited by this paper
• Ubiquitin ligases, critical mediators of endoplasmic reticulum-associated degradation.

  2007cited by this paper
• Comparative Evaluation of Tandem MS Search Algorithms Using a Target-Decoy Search Strategy*S

  2007cited by this paper
• The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

  2007cited by this paper
• Endoplasmic Reticulum-Associated Degradation of Cytochrome P450 CYP3A4 in Saccharomyces cerevisiae: Further Characterization of Cellular Participants and Structural Determinants

  2006cited by this paper
• A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.

  2006cited by this paper
• Nitric Oxide-dependent Proteasomal Degradation of Cytochrome P450 2B Proteins*

  2006cited by this paper
• Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation*

  2006cited by this paper
• The E3 ubiquitin ligase CHIP binds the androgen receptor in a phosphorylation-dependent manner.

  2006cited by this paper
• CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation.

  2006cited by this paper
• The ubiquitin-proteasome pathway in cell cycle control.

  2006cited by this paper
• Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme.

  2005cited by this paper
• Enhanced Ubiquitylation and Accelerated Degradation of the Dopamine Transporter Mediated by Protein Kinase C*

  2005cited by this paper
• SCF-mediated protein degradation and cell cycle control

  2005cited by this paper
• Vacuolar Degradation of Rat Liver CYP2B1 in Saccharomyces cerevisiae: Further Validation of the Yeast Model and Structural Implications for the Degradation of Mammalian Endoplasmic Reticulum P450 Proteins

  2005cited by this paper
• Regulation of Cytochrome P450 by Posttranslational Modification

  2005cited by this paper
• Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS.

  2005cited by this paper
• Cytochrome P450 ubiquitination: branding for the proteolytic slaughter?

  2005cited by this paper
• Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradation.

  2005cited by this paper
• Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase

  2005cited by this paper
• CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival*

  2004cited by this paper
• Distinct Machinery Is Required in Saccharomyces cerevisiae for the Endoplasmic Reticulum-associated Degradation of a Multispanning Membrane Protein and a Soluble Luminal Protein*

  2004cited by this paper
• Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.

  2004cited by this paper
• Human HRD1 Is an E3 Ubiquitin Ligase Involved in Degradation of Proteins from the Endoplasmic Reticulum*

  2004cited by this paper
• Hepatic Cytochrome P450 Degradation: Mechanistic Diversity of the Cellular Sanitation Brigade

  2003cited by this paper
• A proteomics approach to understanding protein ubiquitination

  2003cited by this paper
• Native CYP2C11: heterologous expression in Saccharomyces cerevisiae reveals a role for vacuolar proteases rather than the proteasome system in the degradation of this endoplasmic reticulum protein.

  2002cited by this paper
• Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae

  2002cited by this paper
• Ethanol withdrawal induced CYP2E1 degradation in vivo, blocked by proteasomal inhibitor PS-341.

  2002cited by this paper
• The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum

  2001cited by this paper
• A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation.

  2001cited by this paper
• Phosphorylation of native and heme-modified CYP3A4 by protein kinase C: a mass spectrometric characterization of the phosphorylated peptides.

  2001cited by this paper
• CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.

  2000cited by this paper
• Identification of a ubiquitination-Target/Substrate-interaction domain of cytochrome P-450 (CYP) 2E1.

  2000cited by this paper
• The regulation of protein function by multisite phosphorylation--a 25 year update.

  2000cited by this paper
• Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase.

  1999cited by this paper
• Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching.

  1999cited by this paper
• Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome?

  1999cited by this paper
• Heterologous expression and kinetic characterization of human cytochromes P-450: validation of a pharmaceutical tool for drug metabolism research.

  1999cited by this paper
• Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes.

  1999cited by this paper
• NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species.

  1999cited by this paper
• Tightly regulated and inducible expression of rabbit CYP2E1 using a tetracycline-controlled expression system.

  1999cited by this paper
• Involvement of Valosin-containing Protein, an ATPase Co-purified with IκBα and 26 S Proteasome, in Ubiquitin-Proteasome-mediated Degradation of IκBα*

  1998cited by this paper
• Identification of the heme-modified peptides from cumene hydroperoxide-inactivated cytochrome P450 3A4.

  1998cited by this paper
• Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha.

  1998cited by this paper
• Evidence of Proteasome-mediated Cytochrome P-450 Degradation*

  1997cited by this paper
• Phosphorylation of Sic1p by G1 Cdk required for its degradation and entry into S phase.

  1997cited by this paper
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

  1997cited by this paper
• Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization.

  1997cited by this paper
• A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p.

  1997cited by this paper
• Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1.

  1997cited by this paper
• Regulating the yeast kinetochore by ubiquitin-dependent degradation and Skp1p-mediated phosphorylation.

  1997cited by this paper
• Yeast expression of animal and plant P450s in optimized redox environments.

  1996cited by this paper
• Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein.

  1996cited by this paper
• Cytochrome P450: Structure, mechanism, and biochemistry

  1996cited by this paper
• Expression and Detection of Inducible Nitric Oxide Synthase in Experimental Models of Inflammation

  1996cited by this paper
• Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.

  1996cited by this paper
• Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway.

  1996cited by this paper
• Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

  1995cited by this paper
• Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

  1995cited by this paper
• Ethanol Induces CYP2E1 by Protein Stabilization

  1995cited by this paper
• Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

  1994cited by this paper
• Evidence against a role for serine 129 in determining murine cytochrome P450 Cyp2e-1 protein levels.

  1994cited by this paper
• Evidence against a role for serine 129 in determining murine cytochrome P450 Cyp2e-1 protein levels.

  1994cited by this paper
• Phosphorylation of cytochrome P4502E1 (CYP2E1) by calmodulin dependent protein kinase, protein kinase C and cAMP dependent protein kinase.

  1993cited by this paper
• Purification and characterization of two membrane bound serine proteinases from rat liver microsomes active in degradation of cytochrome P450.

  1993cited by this paper
• Degradation of cytochrome P450 2E1: selective loss after labilization of the enzyme.

  1992cited by this paper
• Hormone- and substrate-regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes.

  1992cited by this paper
• Degradation of rat liver cytochromes P450 3A after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: characterization of the proteolytic system.

  1992cited by this paper
• Acetone-regulated synthesis and degradation of cytochrome P450E1 and cytochrome P4502B1 in rat liver [corrected].

  1991cited by this paper
• Post-translational reduction of cytochrome P450IIE by CCl4, its substrate.

  1991cited by this paper
• Acetone-regulated synthesis and degradation of cytochrome P4502E2 and cytochrome P4502B1 in rat liver

  1991cited by this paper
• Cytochrome P450 turnover.

  1991cited by this paper
• Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation.

  1990cited by this paper
• Phosphorylation of hepatic phenobarbital‐inducible cytochrome P‐450.

  1989cited by this paper
• Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization.

  1989cited by this paper

• Protein subinteractomes of human microsomal cytochromes P450

  2025cites this paper
• Liver CYP4A autophagic lysosomal degradation: A major role for the autophagic receptor SQSTM1/p62 through an uncommon target interaction site

  2024cites this paper
• The Discovery of Gut Microbial Metabolites as Modulators of Host Susceptibility to Acetaminophen-Induced Hepatotoxicity

  2024influential citation
• Hydrogen Peroxide Induces Ethanol-inducible CYP2E1 via the NFkB-classical Pathway: CYP2E1 mRNA Levels are not High in Alcoholic Hepatitis.

  2024cites this paper
• Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver

  2022cites this paper
• Phosphodiesterase 4 mRNA Level Suppression is Important for Extract of Black Carrot to Protect Against Hepatic Injury Induced by Ethanol

  2022cites this paper
• Prenatal ethanol exposure induces dynamic changes of expression and activity of hepatic cytochrome P450 isoforms in male rat offspring.

  2022cites this paper
• Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization

  2022cites this paper
• Disulfiram Oxy-Derivatives Suppress Protein Retrotranslocation across the ER Membrane to the Cytosol and Initiate Paraptosis-like Cell Death

  2022cites this paper
• Characterization of the Structural Determinants of the Ubiquitin-Dependent Proteasomal Degradation of Human Hepatic Tryptophan 2,3-Dioxygenase.

  2021cites this paper
• CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload

  2021cites this paper
• Chaperone-assisted E3 ligase CHIP: A double agent in cancer

  2021cites this paper
• Ubiquitin pathways regulate the pathogenesis of chronic liver disease.

  2021cites this paper
• Effects of long‐term ethanol ingestion on hepatic iron metabolism in two mouse strains

  2020cites this paper
• Why Hepatic CYP2E1-Elevation by Itself Is Insufficient for Inciting NAFLD/NASH: Inferences from Two Genetic Knockout Mouse Models

  2020cites this paper
• Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications

  2019cites this paper
• Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications.

  2019cites this paper
• Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-Ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance

  2019cites this paper
• Human hepatic tryptophan 2,3-dioxygenase ubiquitin-dependent protein degradation: The critical role of its exosite as the molecular lynchpin of its substrate-mediated protein stabilization

  2019cites this paper
• Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit

  2018cites this paper
• Posttranslational regulation of CYP2J2 by nitric oxide

  2018cites this paper
• Effect of Oridonin on Cytochrome P450 Expression and Activities in HepaRG Cell

  2018cites this paper
• Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

  2018cites this paper
• Transmembrane helix hydrophobicity is an energetic barrier during the retrotranslocation of integral membrane ERAD substrates

  2017cites this paper
• Coat Protein Regulation by CK2, CPIP, HSP70, and CHIP Is Required for Potato Virus A Replication and Coat Protein Accumulation

  2016cites this paper
• Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame

  2016influential citation
• Diverse Regulation of the CreA Carbon Catabolite Repressor in Aspergillus nidulans

  2016cites this paper
• Molecular basis for catalysis and substrate-mediated cellular stabilization of human tryptophan 2,3-dioxygenase

  2016cites this paper
• CHIP−/−-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications

  2016cites this paper
• Acetaminophen induces accumulation of functional rat CYP3A via polyubiquitination dysfunction

  2016cites this paper
• Comprehensive Analysis of in Vivo Phosphoproteome of Mouse Liver Microsomes.

  2015cites this paper
• Permanent uncoupling of male-specific CYP2C11 transcription/translation by perinatal glutamate.

  2015cites this paper
• A CHIPotle in physiology and disease.

  2015cites this paper
• The E3 ubiquitin ligase gp78 protects against ER stress in zebrafish liver.

  2014cites this paper
• The characteristics of Bax inhibitor-1 and its related diseases.

  2014cites this paper
• The E3 Ligase CHIP: Insights into Its Structure and Regulation

  2014cites this paper
• Human Liver Cytochrome P450 3A4 Ubiquitination

  2014cites this paper
• Hepatic cytochrome P450 ubiquitination: Conformational phosphodegrons for E2/E3 recognition?

  2014cites this paper
• Highly expressed protein kinase A inhibitor α and suppression of protein kinase A may potentiate acetaminophen-induced hepatotoxicity.

  2014cites this paper
• Growth hormone-independent suppression of growth hormone-dependent female isoforms of cytochrome P450 by the somatostatin analog octreotide.

  2013cites this paper
• Cytochrome P450 2E1: its clinical aspects and a brief perspective on the current research scenario.

  2013cites this paper
• Regulation of hepatic ER stress by the E3 ubiquitin ligase gp78 in zebrafish

  2012influential citation
• In vivo Introduced Extracellular Ubiquitin Regulates Intracellular Processes

  2012cites this paper
• Accumulation of cytochrome P450 induced by proteasome inhibition during cardiac ischemia.

  2012cites this paper
• Ubiquitination of Neuronal Nitric-oxide Synthase in the Calmodulin-binding Site Triggers Proteasomal Degradation of the Protein*

  2012cites this paper
• gp78: a multifaceted ubiquitin ligase that integrates a unique protein degradation pathway from the endoplasmic reticulum.

  2012cites this paper
• Bax inhibitor-1 regulates the expression of P450 2E1 through enhanced lysosome activity.

  2012cites this paper
• Chaperone-dependent Ubiquitination of Neuronal Nitric Oxide Synthase

  2012cites this paper
• Multisite Phosphorylation of Human Liver Cytochrome P450 3A4 Enhances Its gp78- and CHIP-mediated Ubiquitination

  2011cites this paper